Rahul Shukla

3.7k total citations
154 papers, 2.5k citations indexed

About

Rahul Shukla is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Rahul Shukla has authored 154 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pharmaceutical Science, 36 papers in Molecular Biology and 26 papers in Biomaterials. Recurrent topics in Rahul Shukla's work include Advanced Drug Delivery Systems (30 papers), Advancements in Transdermal Drug Delivery (23 papers) and Nanoparticle-Based Drug Delivery (21 papers). Rahul Shukla is often cited by papers focused on Advanced Drug Delivery Systems (30 papers), Advancements in Transdermal Drug Delivery (23 papers) and Nanoparticle-Based Drug Delivery (21 papers). Rahul Shukla collaborates with scholars based in India, Saudi Arabia and United States. Rahul Shukla's co-authors include Prashant Kesharwani, Mayank Handa, Ajit Singh, S.J.S. Flora, Rahul Kumar Verma, Rewati Raman Ujjwal, Sunil Kumar Dubey, Kamalinder K. Singh, Sima Singh and Nagashekhara Molugulu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Biomacromolecules.

In The Last Decade

Rahul Shukla

142 papers receiving 2.4k citations

Peers

Rahul Shukla

BIOMA

Sarika Wairkar India

Rajendra Awasthi India

Bhupendra G. Prajapati India

Lan Shen China

Gaurav Jain India

Sajid Asghar Pakistan

Alam Zeb Pakistan

Gowthamarajan Kuppusamy India

Khalid Saad Alharbi Saudi Arabia

Deepti Pandita India

Sarika Wairkar India

Rahul Shukla

565 ×0.8

598 ×0.9

464 ×0.8

BIOMA

410 ×0.9

290 ×1.3

Citations per year, relative to Rahul Shukla Rahul Shukla (= 1×) peers Sarika Wairkar

Countries citing papers authored by Rahul Shukla

Since Specialization

Citations

This map shows the geographic impact of Rahul Shukla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahul Shukla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahul Shukla more than expected).

Fields of papers citing papers by Rahul Shukla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rahul Shukla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahul Shukla. The network helps show where Rahul Shukla may publish in the future.

Co-authorship network of co-authors of Rahul Shukla

This figure shows the co-authorship network connecting the top 25 collaborators of Rahul Shukla. A scholar is included among the top collaborators of Rahul Shukla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rahul Shukla. Rahul Shukla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kumari, Anchala, et al.. (2025). siRNA-based Therapeutics in Hormone-driven Cancers: Advancements and benefits over conventional treatments. International Journal of Pharmaceutics. 674. 125463–125463. 1 indexed citations

Shukla, Rahul, et al.. (2025). Intranasal Apocynin-loaded nanostructured lipid carriers (NLCs) for Alzheimer's disease therapy: Formulation, optimization, and pharmacokinetic evaluations. Journal of Drug Delivery Science and Technology. 108. 106862–106862. 5 indexed citations

Gowda, B.H. Jaswanth, et al.. (2025). Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy. Clinical Pharmacology Advances and Applications. Volume 17. 119–141.

Verma, Rahul Kumar, et al.. (2025). Intranasal Therapeutics for Neurodegenerative Disorders: Overcoming the Blood–Brain Barrier with Smart Formulations and Devices. Molecular Pharmaceutics. 22(7). 3602–3620. 2 indexed citations

Gupta, Piyush Kumar, et al.. (2025). Synergy of Microfluidics and Nanomaterials: A Revolutionary Approach for Cancer Management. ACS Applied Bio Materials. 8(4). 2716–2734. 2 indexed citations

Kesharwani, Payal, Amit Alexander, Rahul Shukla, et al.. (2024). Tissue regeneration properties of hydrogels derived from biological macromolecules: A review. International Journal of Biological Macromolecules. 271(Pt 2). 132280–132280. 26 indexed citations

Shukla, Rahul, et al.. (2024). Recent advancements in microspheres mediated targeted delivery for therapeutic interventions in osteoarthritis. Journal of Microencapsulation. 41(6). 434–455. 3 indexed citations

Alshehri, Saad Ali, et al.. (2024). Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand. European Polymer Journal. 215. 113244–113244. 1 indexed citations

Bisht, Akansha, et al.. (2023). Systematic optimization, characterization of Mycophenolic acid loaded nanostructured lipid carrier embedd ed nanogel for improved permeation and in vivo antipsoriatic activity. Journal of Drug Delivery Science and Technology. 89. 105088–105088. 5 indexed citations

10.

Bisht, Akansha, et al.. (2023). Cedrus deodara (Roxb. ex D.Don) G.Don bark fraction ameliorates metabolic, endocrine and ovarian dynamics in rats experiencing polycystic ovarian syndrome. Journal of Ethnopharmacology. 306. 116206–116206. 10 indexed citations

11.

Singh, Ajit, et al.. (2023). ApoE3 Anchored Liposomal Delivery of Rivastigmine for Brain Delivery: Formulation, Characterization, and In Vivo Pharmacokinetic Evaluation. AAPS PharmSciTech. 24(8). 223–223. 9 indexed citations

12.

Lam, Megan, et al.. (2023). Fox-Fordyce disease treated with fractional CO2 laser: A case report. JAAD Case Reports. 37. 5–7.

13.

Pandey, Rukmani, et al.. (2023). Role of NLRP3 Inflammasome in Stroke Pathobiology: Current Therapeutic Avenues and Future Perspective. ACS Chemical Neuroscience. 15(1). 31–55. 9 indexed citations

14.

Shukla, Rahul, et al.. (2023). Monitoring Primary Frequency Response using high resolution data from Wide Area Measurement Systems. 1–2.

15.

Molugulu, Nagashekhara, Sivakumar Annadurai, Shadma Wahab, et al.. (2023). Hyaluronic acid-functionalized lipoplexes and polyplexes as emerging nanocarriers for receptor-targeted cancer therapy. Environmental Research. 233. 116506–116506. 35 indexed citations

16.

Handa, Mayank, Ajit Singh, Dheeraj Bisht, Prashant Kesharwani, & Rahul Shukla. (2022). Potential of particle size less than 15 nm via olfactory region for direct brain delivery via intranasal route. SHILAP Revista de lepidopterología. 4. 100038–100038. 16 indexed citations

17.

Gowda, B.H. Jaswanth, Mohammed Gulzar Ahmed, Amirhossein Sahebkar, et al.. (2022). Stimuli-Responsive Microneedles as a Transdermal Drug Delivery System: A Demand-Supply Strategy. Biomacromolecules. 23(4). 1519–1544. 73 indexed citations

18.

Kesharwani, Prashant, Rahul Shukla, Gaurav Jain, et al.. (2022). Recent advances in multifunctional dendrimer-based nanoprobes for breast cancer theranostics. Journal of Biomaterials Science Polymer Edition. 33(18). 2433–2471. 19 indexed citations

19.

Singh, Ajit, et al.. (2021). Viral vectors as a promising nanotherapeutic approach against neurodegenerative disorders. Process Biochemistry. 109. 130–142. 8 indexed citations

20.

Singh, Ajit, Bapi Gorain, Awesh K. Yadav, et al.. (2021). Quantum dot: Heralding a brighter future in neurodegenerative disorders. Journal of Drug Delivery Science and Technology. 65. 102700–102700. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact